Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • IHH Healthcare open...

    IHH Healthcare open offer to acquistion of 26% stake in Fortis to commence on Dec 18

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-12-14T09:15:07+05:30  |  Updated On 14 Dec 2018 9:15 AM IST
    IHH Healthcare open offer to acquistion of 26% stake in Fortis to commence on Dec 18

    New Delhi: The open offer by Malaysian firm IHH Healthcare Berhad to acquire additional 26 per cent stake in Fortis Healthcare will commence on December 18 and close on January 1, 2019, a regulatory filing by managers of the offer said.


    A letter of the offer to Fortis shareholders was submitted to the bourses by the managers to open offer -- HSBC Securities and Capital Markets (India) Pvt Ltd, HDFC Bank Ltd, Citigroup Global Markets India Pvt Ltd and Deutsche Equities India Pvt Ltd.


    Read Also: CCI approves IHH acquisition of Fortis Healthcare, Fortis Malar Hospital


    Northern TK Venture Pte Ltd together with IHH Healthcare Berhad and Parkway Pantai Ltd have made an open offer to the equity shareholders of Fortis Healthcare to acquire up to 197 million shares, representing 26 per cent of the expanded voting share capital, at a price of Rs 170 per share payable in cash, the letter said.


    The tendering period will commence on December 18, 2018, and will close on January 1, 2019, it added.


    Earlier on November 13, Fortis Healthcare said it had issued 235.3 million equity shares through preferential allotment to IHH Healthcare Berhad for around Rs 40 billion, a move that helps the Malaysian firm take 31.1 per cent stake in the company. The allotment was done at Rs 170 per share.


    Also Read: IHH Healthcare completes Fortis Acquisition, Appoints 4 Directors on Board

    CCIFHLFortisFortis HealthcareFortis Healthcare LtdFortis Malar HospitalFortis Memorial Research InstituteHealthcareIHHIHH Healthcare BerhadReligare Health Trust
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok